A worse prognosis for men with testicular atrophy at therapeutic orchiectomy for prostate carcinoma
نویسندگان
چکیده
منابع مشابه
Hip fractures in men with prostate cancer treated with orchiectomy.
PURPOSE Androgen deprivation therapy increases the risk of osteoporosis related fractures. This issue is of increasing importance in men with prostate cancer as increasingly more undergo androgen deprivation therapy and therapy is administered sooner following diagnosis. Data directly addressing the long-term fracture risk in men diagnosed with prostate cancer are limited. MATERIALS AND METHO...
متن کاملTesticular torsion: orchiectomy or orchiopexy?
OBJECTIVE To evaluate the impact on testicular function of the surgical approach used to treat testicular torsion. PATIENTS AND METHODS Seventeen males operated on for testicular torsion at a median age of 14 years were investigated. Serum follicle-stimulating hormone (FSH), testosterone and inhibin B as well as testicular volume were measured early (median 36 days) and/or late (median 1.1 ye...
متن کاملPsychosocial implications and the duality of life outcomes for patients with prostate carcinoma after bilateral orchiectomy.
OBJECTIVES The study presented focuses on patients' psychosocial status after a prostate cancer diagnosis that underwent a bilateral orchiectomy. METHODS We evaluated the psychosocial implications of 89 patients with prostate cancer after performing castration and a bilateral orchiectomy. RESULTS Patients suffered significantly more from sleep disorders during hospitalisation when compared ...
متن کاملTesticular metastases from prostate carcinoma.
Metastasis of prostate carcinoma to the testis is seldom reported. The tumour may spread from the prostatic urethra by retrograde venous extension, arterial embolism or through direct invasion into the lymphatics and lumen of the vas deferens. Clinical manifestations of secondary testicular tumours from the prostate are most often unsuspected clinically and are instead detected incidentally dur...
متن کاملBilateral orchiectomy with or without flutamide for metastatic prostate cancer.
BACKGROUND Combined androgen blockade for the treatment of metastatic prostate cancer consists of an antiandrogen drug plus castration. In a previous trial, we found that adding the antiandrogen flutamide to leuprolide acetate (a synthetic gonadotropin-releasing hormone that results in medical ablation of testicular function) significantly improved survival as compared with that achieved with p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1998
ISSN: 0008-543X,1097-0142
DOI: 10.1002/(sici)1097-0142(19980915)83:6<1170::aid-cncr16>3.0.co;2-2